US Patent Issued to Kenkichi Masutomi on March 17 for "Screening method for telomerase reverse transcriptase (TERT) phosphorylation inhibitors" (Japanese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,555, issued on March 17, was assigned to Kenkichi Masutomi (Tokyo).

"Screening method for telomerase reverse transcriptase (TERT) phosphorylation inhibitors" was invented by Kenkichi Masutomi (Tokyo) and Mami Yasukawa (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for screening for a telomerase reverse transcriptase (TERT) phosphorylation inhibitor using TERT or a fragment thereof, and a TERT kinase."

The patent was filed on Dec. 14, 2018, under Application No. 16/770,693.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2...